Physician profile
David Shih
NPI 1992895601
$25,957.54
in general payments reported to CMS, 2019-2025
38 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 77% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,162 · 2020: $4,078 · 2021: $9,243 · 2022: $4,698 · 2023: $2,159 · 2024: $2,808 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,678 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,678.06 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $8,565.65 | 2020-2024 | Talicia, Aemcolo, Movantik |
| Abbvie INC. | $4,610.48 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Ferring Pharmaceuticals INC. | $4,423.61 | 2019-2024 | Rebyota |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,075.05 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Janssen Biotech, INC. | $1,074.45 | 2021-2025 | Stelara, Tremfya, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $1,043.21 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Gilead Sciences, INC. | $978.88 | 2019-2025 | |
| Genzyme Corporation | $659.28 | 2022-2025 | |
| Aimmune Therapeutics, INC. | $487.00 | 2024-2025 | Zenpep |
| Ironwood Pharmaceuticals, INC | $409.82 | 2019-2024 | Linzess |
| Nestle Healthcare Nutrition INC. | $389.07 | 2021-2023 | |
| Braintree Laboratories, INC. | $340.80 | 2019-2024 | Sutab, Suflave |
| Qol Medical, LLC | $295.47 | 2019-2024 | Sucraid |
| Merck Sharp & Dohme LLC | $157.52 | 2019-2024 | Dificid |
| Orphalan INC | $135.85 | 2024-2025 | Cuvrior |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $127.59 | 2020-2025 | |
| Ardelyx, INC. | $114.56 | 2022-2024 | Ibsrela |
| Celgene Corporation | $113.24 | 2021-2023 | Zeposia |
| Alfasigma USA, INC. | $105.02 | 2020-2021 | |
| Ucb, INC. | $102.11 | 2019-2022 | |
| Shionogi INC | $81.13 | 2019 | |
| Phathom Pharmaceuticals, INC. | $69.56 | 2024-2025 | Voquezna |
| Boston Scientific Corporation | $64.19 | 2020 | |
| Enterra Medical, INC. | $63.59 | 2023 | |
| Intercept Pharmaceuticals, INC. | $58.58 | 2020-2024 | Ocaliva |
| Celltrion USA INC. | $57.38 | 2024-2025 | Vegzelma |
| Regeneron Healthcare Solutions, INC. | $51.51 | 2023 | Dupixent |
| Lilly USA, LLC | $48.81 | 2023-2025 | Omvoh |
| Organon LLC | $41.65 | 2022-2023 | Hadlima |
| Ethicon US, LLC | $37.05 | 2019 | |
| Mallinckrodt Hospital Products INC. | $31.24 | 2024 | Terlivaz |
| Shire North American Group INC | $28.05 | 2019 | |
| Daiichi Sankyo INC. | $24.87 | 2019-2020 | |
| Madrigal Pharmaceuticals | $23.68 | 2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals LP | $20.18 | 2022 | |
| Exact Sciences Corporation | $18.59 | 2023 | Cologuard Collection Kit |
| Endogastric Solutions, INC | $16.07 | 2024 | Esophyx |
| Medtronic, INC. | $12.75 | 2023 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shih listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.